Clinical Trials Logo

Clinical Trial Summary

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.


Clinical Trial Description

This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by the Cancer-related cognitive impairment (CRCI) and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of the Cancer-related cognitive impairment (CRCI) and associated cognitive changes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05186948
Study type Observational
Source Innodem Neurosciences
Contact
Status Not yet recruiting
Phase
Start date January 20, 2022
Completion date January 20, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05030792 - An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors N/A
Recruiting NCT04565769 - Cognitive Function in Patients Treated for Metastatic Melanoma With Immune Checkpoint Inhibitors
Recruiting NCT02661308 - Reducing Cancer Side-effects With Systematic Light Exposure N/A
Completed NCT03452436 - Testosterone, Cognition, Ageing, and Cancer
Recruiting NCT04667689 - An Online Cognitive Assessment in Cancer Patients Phase 2